Discusses the structure of the two naturally occurring human lysozyme variants that are involved in amyloid fibrils that underlie a range of fatal diseases. The native folds of amyloidogenic variants; The instability of the lysozyme variants; Fibril formation; The reversible nature of fibrillogenesis; Stabilized molten globule intermediate.